U. S.  SECURITIES AND EXCHANGE COMMISSION
                         Washington, D.C. 20549
                                                                 
            FORM 10-QSB -- QUARTERLY OR TRANSITIONAL REPORT
             (Added by 34-30968, eff.  8/13/93, as amended)
                                   
(Mark One)
[  X  ]  QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES
         EXCHANGE ACT OF 1934

For the quarterly period ended SEPTEMBER 30, 1995
                                   
[    ]   TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES 
         EXCHANGE  ACT OF  1934
                                   
For the transition period from               to
                                   
Commission file number 0-17032
                                   
                             PROTEIN DATABASES, INC.
   (Exact name of small business issuer as specified in its charter)
                                   
     DELAWARE                                             13-318660
(State or other jurisdiction of
incorporation or orgainization                            (I.R.S. Employer
                                                           Identification No.)  

405 OAKWOOD ROAD, HUNTINGTON STATION, NEW YORK                11746
(Address of principle executive offices)                    (Zip Code)

 (516) 673-3939
Issuer's telephone number

_____________________________________________________________________
(Former name, former address and former fiscal year, if changed since
                             last report)

Check  whether the issuer (1) filed all reports required to be  filed
by  Section 13 or 15(d) of the Exchange Act during the past 12 months
(or  for such shorter period that the registrant was required to file
such  reports), and (2) has been subject to such filing  requirements
for the past 90 days. Yes - x.  No.

State  the  number  of  shares outstanding of each  of  the  issuer's
classes of common equity, as of the latest practicable date.

Class                               Outstanding at September 30, 1995
Common Stock $.01 par value                   1,459,741
                                                                      
<PAGE>                                   
 
  PART II - OTHER INFORMATION

Item 6.   Exhibits and Reports on Form 8-K

     ( a )     Exhibits: EX-27

     ( b )     Reports on Form 8-K:  There were no reports  on Form  8-K 
               filed by the Company during the three months ended 
               September 30, 1995.

<PAGE>

	INDEX TO EXHIBITS

27    -Financial Data Schedule

<PAGE>

    FINANCIAL DATA SCHEDULE     EXHIBIT 27

[DESCRIPTION] ART. 5 FDS FOR 3RD QUARTER 10-Q
[ARTICLE] 5
[LEGEND]
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION
EXTRACTED FROM PROTEIN DATABASES, INC'S SEPTEMBER 30,1995
FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATMENTS.
[NAME] PROTEIN DATABASES, INC. 
<TABLE>
<S>                             <C>
[PERIOD-TYPE]                   9-MOS
[FISCAL-YEAR-END]                          DEC-31-1995
[PERIOD-END]                               SEP-30-1995
[CASH]                                         900,720
[SECURITIES]                                         0
[RECEIVABLES]                                  428,188
[ALLOWANCES]                                         0
[INVENTORY]                                     27,786
[CURRENT-ASSETS]                             1,375,444
[PP&E]                                         908,769
[DEPRECIATION]                               (661,794)
[TOTAL-ASSETS]                               1,635,935
[CURRENT-LIABILITIES]                          189,901
[BONDS]                                              0
[PREFERRED-MANDATORY]                                0
[PREFERRED]                                          0
[COMMON]                                        14,597
[OTHER-SE]                                   1,431,441
[TOTAL-LIABILITY-AND-EQUITY]                 1,635,939
[SALES]                                      2,190,108
[TOTAL-REVENUES]                             2,190,108
[CGS]                                          491,588
[TOTAL-COSTS]                                  491,588
[OTHER-EXPENSES]                             1,574,415
[LOSS-PROVISION]                                     0
[INTEREST-EXPENSE]                                   0
[INCOME-PRETAX]                                124,105
[INCOME-TAX]                                     2,500
[INCOME-CONTINUING]                            121,605
[DISCONTINUED]                                       0
[EXTRAORDINARY]                                      0
[CHANGES]                                            0
[NET-INCOME]                                   121,605
[EPS-PRIMARY]                                      .07
[EPS-DILUTED]                                      .07
</TABLE>